Cancer Research  Translational Medicine Conference in Israel
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ochs, K.
Right arrow Articles by Kaina, B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ochs, K.
Right arrow Articles by Kaina, B.
[Cancer Research 60, 5815-5824, October 15, 2000]
© 2000 American Association for Cancer Research


Molecular Biology and Genetics

Apoptosis Induced by DNA Damage O6 -Methylguanine Is Bcl-2 and Caspase-9/3 Regulated and Fas/Caspase-8 Independent,1

Kirsten Ochs and Bernd Kaina2

Division of Applied Toxicology, Institute of Toxicology, University of Mainz, D-55131 Mainz, Germany

In the therapy of various kinds of tumors, methylating agents generating O6-methylguanine (O6MeG) in DNA are used. We studied the molecular mechanism of cell death induced by these agents by comparing isogenic cell lines proficient (MGMT+) and deficient (MGMT-) for the DNA repair protein alkyltransferase and exhibiting the tolerance phenotype. Hypersensitivity to methylation-induced cell killing of MGMT- cells is attributable to the potent induction of apoptosis. We show that apoptosis is a late event occurring >48 h after methylation. It was preceded by decrease in Bcl-2 protein level and accompanied by activation of caspase-9 and caspase-3. We also observed cytochrome c release and hypophosphorylation of Bad. Other members of the Bcl-2 family (Bag-1, Bak, Bax, and Bcl-xL) were not altered in expression. Transfection of MGMT- cells with bcl-2 protected against methylation-induced apoptosis, indicating that Bcl-2 plays a key role in the response. Induction of apoptosis in MGMT- cells was not triggered by Fas and Fas ligand (CD95, Apo-1) because both proteins remained unaltered in expression and receptor-proximal caspase-8 was not activated after methylation. Also, inhibition of caspase-8 was ineffective in modifying the apoptotic response, whereas inhibition of caspase-3 and caspase-9 blocked apoptosis. Tolerant cells that are unable to repair O6MeG and are impaired in mismatch repair were less sensitive regarding the induction of apoptosis and Bcl-2 decline, supporting the view that O6MeG-induced apoptosis requires mismatch repair. The ultimate O6MeG-derived lesions triggering the apoptotic pathway are likely to be DNA double-strand breaks, which were significantly formed in MGMT- but not in MGMT+ and tolerant cells and which preceded apoptosis. Overall, the data indicate that O6MeG induces apoptosis via secondary lesions that trigger Bcl-2 decline, cytochrome c release, and caspase-9 and caspase-3 activation independently of Fas/Fas ligand and p53, for which the cells are mutated.




This article has been cited by other articles:


Home page
JCOHome page
M. E. Hegi, L. Liu, J. G. Herman, R. Stupp, W. Wick, M. Weller, M. P. Mehta, and M. R. Gilbert
Correlation of O6-Methylguanine Methyltransferase (MGMT) Promoter Methylation With Clinical Outcomes in Glioblastoma and Clinical Strategies to Modulate MGMT Activity
J. Clin. Oncol., September 1, 2008; 26(25): 4189 - 4199.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
M. Sanada, M. Hidaka, Y. Takagi, T. Y. Takano, Y. Nakatsu, T. Tsuzuki, and M. Sekiguchi
Modes of actions of two types of anti-neoplastic drugs, dacarbazine and ACNU, to induce apoptosis
Carcinogenesis, December 1, 2007; 28(12): 2657 - 2663.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
W.-J. Kim, B. Rajasekaran, and K. D. Brown
MLH1- and ATM-dependent MAPK Signaling Is Activated through c-Abl in Response to the Alkylator N-Methyl-N'-nitro-N'-nitrosoguanidine
J. Biol. Chem., November 2, 2007; 282(44): 32021 - 32031.
[Abstract] [Full Text] [PDF]


Home page
JCOHome page
R. Stupp, M. E. Hegi, M. R. Gilbert, and A. Chakravarti
Chemoradiotherapy in Malignant Glioma: Standard of Care and Future Directions
J. Clin. Oncol., September 10, 2007; 25(26): 4127 - 4136.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
B. Yamini, X. Yu, M. E. Dolan, M. H. Wu, D. W. Kufe, and R. R. Weichselbaum
Inhibition of Nuclear Factor-{kappa}B Activity by Temozolomide Involves O6-Methylguanine Induced Inhibition of p65 DNA Binding
Cancer Res., July 15, 2007; 67(14): 6889 - 6898.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
V. O'Brien and R. Brown
Signalling cell cycle arrest and cell death through the MMR System
Carcinogenesis, April 1, 2006; 27(4): 682 - 692.
[Abstract] [Full Text] [PDF]


Home page
J. Mol. Diagn.Home page
E. J. Fox, D. T. Leahy, R. Geraghty, H. E. Mulcahy, D. Fennelly, J. M. Hyland, D. P. O'Donoghue, and K. Sheahan
Mutually Exclusive Promoter Hypermethylation Patterns of hMLH1 and O6-Methylguanine DNA Methyltransferase in Colorectal Cancer
J. Mol. Diagn., February 1, 2006; 8(1): 68 - 75.
[Abstract] [Full Text] [PDF]


Home page
Nucleic Acids ResHome page
M. Hidaka, Y. Takagi, T. Y. Takano, and M. Sekiguchi
PCNA-MutS{alpha}-mediated binding of MutL{alpha} to replicative DNA with mismatched bases to induce apoptosis in human cells
Nucleic Acids Res., October 4, 2005; 33(17): 5703 - 5712.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
E. Peterson-Roth, M. Reynolds, G. Quievryn, and A. Zhitkovich
Mismatch Repair Proteins Are Activators of Toxic Responses to Chromium-DNA Damage
Mol. Cell. Biol., May 1, 2005; 25(9): 3596 - 3607.
[Abstract] [Full Text] [PDF]


Home page
NEJMHome page
M. E. Hegi, A.-C. Diserens, T. Gorlia, M.-F. Hamou, N. de Tribolet, M. Weller, J. M. Kros, J. A. Hainfellner, W. Mason, L. Mariani, et al.
MGMT Gene Silencing and Benefit from Temozolomide in Glioblastoma
N. Engl. J. Med., March 10, 2005; 352(10): 997 - 1003.
[Abstract] [Full Text] [PDF]


Home page
Molecular Cancer TherapeuticsHome page
V. A. Barvaux, P. Lorigan, M. Ranson, A. M. Gillum, R. S. McElhinney, T. B. H. McMurry, and G. P. Margison
Sensitization of a human ovarian cancer cell line to temozolomide by simultaneous attenuation of the Bcl-2 antiapoptotic protein and DNA repair by O6-alkylguanine-DNA alkyltransferase
Mol. Cancer Ther., October 1, 2004; 3(10): 1215 - 1220.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
E. Gonzalez-Suarez, F. A. Goytisolo, J. M. Flores, and M. A. Blasco
Telomere Dysfunction Results in Enhanced Organismal Sensitivity to the Alkylating Agent N-Methyl-N-Nitrosourea
Cancer Res., November 1, 2003; 63(21): 7047 - 7050.
[Abstract] [Full Text] [PDF]


Home page
IOVSHome page
D. Petrin, A. Baker, S. G. Coupland, P. Liston, M. Narang, K. Damji, B. Leonard, V. A. Chiodo, A. Timmers, W. Hauswirth, et al.
Structural and Functional Protection of Photoreceptors from MNU-Induced Retinal Degeneration by the X-Linked Inhibitor of Apoptosis
Invest. Ophthalmol. Vis. Sci., June 1, 2003; 44(6): 2757 - 2763.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
M. T. Tomicic, C. Friedrichs, M. Christmann, P. Wutzler, R. Thust, and B. Kaina
Apoptosis Induced by (E)-5-(2-Bromovinyl)-2'-deoxyuridine in Varicella Zoster Virus Thymidine Kinase-Expressing Cells Is Driven by Activation of c-Jun/Activator Protein-1 and Fas Ligand/Caspase-8
Mol. Pharmacol., February 1, 2003; 63(2): 439 - 449.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
A. W. Adamson, W.-J. Kim, S. Shangary, R. Baskaran, and K. D. Brown
ATM Is Activated in Response to N-Methyl-N'-nitro- N-nitrosoguanidine-induced DNA Alkylation
J. Biol. Chem., October 4, 2002; 277(41): 38222 - 38229.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
T. J. Page, S. O'Brien, C. R. Jefcoate, and C. J. Czuprynski
7,12-Dimethylbenz[a]anthracene Induces Apoptosis in Murine Pre-B Cells through a Caspase-8-Dependent Pathway
Mol. Pharmacol., August 1, 2002; 62(2): 313 - 319.
[Abstract] [Full Text] [PDF]


Home page
Nucleic Acids ResHome page
M. Christmann, M. T. Tomicic, and B. Kaina
Phosphorylation of mismatch repair proteins MSH2 and MSH6 affecting MutS{alpha} mismatch-binding activity
Nucleic Acids Res., May 1, 2002; 30(9): 1959 - 1966.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
S. Mohr, X. Xi, J. Tang, and T. S. Kern
Caspase Activation in Retinas of Diabetic and Galactosemic Mice and Diabetic Patients
Diabetes, April 1, 2002; 51(4): 1172 - 1179.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
K. Ochs, J. Lips, S. Profittlich, and B. Kaina
Deficiency in DNA Polymerase {beta} Provokes Replication-dependent Apoptosis via DNA Breakage, Bcl-2 Decline and Caspase-3/9 Activation
Cancer Res., March 1, 2002; 62(5): 1524 - 1530.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
J. Lips and B. Kaina
DNA double-strand breaks trigger apoptosis in p53-deficient fibroblasts
Carcinogenesis, April 1, 2001; 22(4): 579 - 585.
[Abstract] [Full Text] [PDF]


Home page
Mol. Biol. CellHome page
T. R. Dunkern and B. Kaina
Cell Proliferation and DNA Breaks Are Involved in Ultraviolet Light-induced Apoptosis in Nucleotide Excision Repair-deficient Chinese Hamster Cells
Mol. Biol. Cell, January 1, 2002; 13(1): 348 - 361.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 2000 by the American Association for Cancer Research.